6 research outputs found

    The Lonely States of America: Prevalence and Demographic Risk Factors for Affection Deprivation among U.S. Adults

    No full text
    As articulated by Floyd (2014), affection deprivation indexes a perceived deficit in the amount of affectionate communication one receives from others. According to affection exchange theory, affection deprivation should be detrimental to both physical and relational health, and empirical evidence supports that assertion. Little is known, however, about the prevalence of affection deprivation in the United States, a topic addressed here in two studies. The first study (N = 2,616) examined demographic and geographic variation in affection deprivation among a non-representative sample of U.S. adults. The latter study (N = 1,121) used a Census-matched representative sample of U.S. adults to replicate assessments of prevalence and also to examine how affection deprivation relates to experiences of loneliness and physical pain

    The transcriptional repressor ID2 supports natural killer cell maturation by controlling TCF1 amplitude

    No full text
    Gaining a mechanistic understanding of the expansion and maturation program of natural killer (NK) cells will provide opportunities for harnessing their inflammation-inducing and oncolytic capacity for therapeutic purposes. Here, we demonstrated that ID2, a transcriptional regulatory protein constitutively expressed in NK cells, supports NK cell effector maturation by controlling the amplitude and temporal dynamics of the transcription factor TCF1. TCF1 promotes immature NK cell expansion and restrains differentiation. The increased TCF1 expression in ID2-deficient NK cells arrests their maturation and alters cell surface receptor expression. Moreover, TCF1 limits NK cell functions, such as cytokine-induced IFN-gamma production and the ability to clear metastatic melanoma in ID2-deficient NK cells. Our data demonstrate that ID2 sets a threshold for TCF1 during NK cell development, thus controlling the balance of immature and terminally differentiated cells that support future NK cell responses.Funding Agencies|National Institutes of Allergy and Infectious DiseasesUnited States Department of Health &amp; Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy &amp; Infectious Diseases (NIAID) [R01 AI106352]; National Cancer InstituteUnited States Department of Health &amp; Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA014599]</p
    corecore